CMMB vs FIS · $22.2M cap vs P/E 7.9, rev $6.67B
Chemomab Therapeutics Ltd DRC (CMMB) versus Fidelity National Information Services Inc (FIS) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
CMMB currently screens at market cap $22.2M. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Not investment advice. Open the CMMB and FIS stock pages for the full models.
Not investment advice.